Alignment Healthcare, Inc.·4

Mar 17, 5:20 PM ET

Mansour Adnan R. 4

4 · Alignment Healthcare, Inc. · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Alignment Healthcare (ALHC) CDO Mansour Adnan R. Receives Award

What Happened
Mansour Adnan R., Chief Digital Officer of Alignment Healthcare (ALHC), received a grant of 25,015 restricted stock units (RSUs) on 2026-03-13. The RSUs were reported at $0.00 per share (no cash exchanged at grant). These are awards (not open-market purchases or sales) and represent a promise to issue one share per RSU upon vesting.

Key Details

  • Transaction date: 2026-03-13; Form 4 filed: 2026-03-17 (timely filing).
  • Grant: 25,015 RSUs; reported acquisition price: $0.00; total reported value at grant: $0.
  • Shares owned after transaction: not disclosed in the provided excerpt.
  • Footnote: The 25,015 RSUs will vest approximately one-third on each of the first three anniversaries of the grant date, subject to continued service (per footnote F1).
  • Transaction type code: A = Award/Grant.

Context
RSU grants are a common form of employee compensation and align executive interests with shareholders over time; they are not an immediate purchase or sale signal. The economic benefit (and any taxable event) will generally occur as RSUs vest and convert to shares.

Insider Transaction Report

Form 4
Period: 2026-03-13
Mansour Adnan R.
Chief Digital Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-13+25,01548,456 total
Footnotes (1)
  • [F1]Represents 25,015 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Adnan R. Mansour|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773782454.xmlPrimary

    FORM 4